112 related articles for article (PubMed ID: 34593428)
1. Linker Threonine-phosphorylated Smad2/3 Is a Biomarker of Colorectal Neoplastic Stem-like Cells that Correlates With Carcinogenesis.
Miyamoto S; Fukui T; Horitani S; Tanimura Y; Matsumoto Y; Suzuki R; Takahashi YU; Kishimoto M; Tomiyama T; Nishio A; Okazaki K; Naganuma M
Anticancer Res; 2021 Oct; 41(10):4789-4799. PubMed ID: 34593428
[TBL] [Abstract][Full Text] [Related]
2. Smad2/3 linker phosphorylation is a possible marker of cancer stem cells and correlates with carcinogenesis in a mouse model of colitis-associated colorectal cancer.
Suzuki R; Fukui T; Kishimoto M; Miyamoto S; Takahashi Y; Takeo M; Mitsuyama T; Sakaguchi Y; Uchida K; Nishio A; Okazaki K
J Crohns Colitis; 2015 Jul; 9(7):565-74. PubMed ID: 25908723
[TBL] [Abstract][Full Text] [Related]
3. Specific Smad2/3 Linker Phosphorylation Indicates Esophageal Non-neoplastic and Neoplastic Stem-Like Cells and Neoplastic Development.
Horitani S; Fukui T; Tanimura Y; Matsumoto Y; Miyamoto S; Tanaka T; Tomiyama T; Ikeura T; Ando Y; Nishio A; Okazaki K
Dig Dis Sci; 2021 Jun; 66(6):1862-1874. PubMed ID: 32705438
[TBL] [Abstract][Full Text] [Related]
4. Phosphorylation of Smad2/3 at specific linker threonine indicates slow-cycling intestinal stem-like cells before reentry to cell cycle.
Kishimoto M; Fukui T; Suzuki R; Takahashi Y; Sumimoto K; Okazaki T; Sakao M; Sakaguchi Y; Yoshida K; Uchida K; Nishio A; Matsuzaki K; Okazaki K
Dig Dis Sci; 2015 Feb; 60(2):362-74. PubMed ID: 25185661
[TBL] [Abstract][Full Text] [Related]
5. Phosphorylation of Smad2/3 at the specific linker threonine residue indicates slow-cycling esophageal stem-like cells before re-entry to the cell cycle.
Takahashi Y; Fukui T; Kishimoto M; Suzuki R; Mitsuyama T; Sumimoto K; Okazaki T; Sakao M; Sakaguchi Y; Yoshida K; Uchida K; Nishio A; Matsuzaki K; Okazaki K
Dis Esophagus; 2016; 29(2):107-15. PubMed ID: 25168378
[TBL] [Abstract][Full Text] [Related]
6. The specific linker phosphorylation of Smad2/3 indicates epithelial stem cells in stomach; particularly increasing in mucosae of Helicobacter-associated gastritis.
Fukui T; Kishimoto M; Nakajima A; Yamashina M; Nakayama S; Kusuda T; Sakaguchi Y; Yoshida K; Uchida K; Nishio A; Matsuzaki K; Okazaki K
J Gastroenterol; 2011 Apr; 46(4):456-68. PubMed ID: 21229365
[TBL] [Abstract][Full Text] [Related]
7. Smad2/3 Linker Phosphorylation Is a Possible Marker of Pancreatic Stem/Progenitor Cells in the Regenerative Phase of Acute Pancreatitis.
Sakao M; Sakaguchi Y; Suzuki R; Takahashi Y; Kishimoto M; Fukui T; Uchida K; Nishio A; Matsuzaki K; Okazaki K
Pancreas; 2017; 46(5):605-613. PubMed ID: 28099259
[TBL] [Abstract][Full Text] [Related]
8. A Short-Term Model of Colitis-Associated Colorectal Cancer That Suggests Initial Tumor Development and the Characteristics of Cancer Stem Cells.
Matsumoto Y; Fukui T; Horitani S; Tanimura Y; Suzuki R; Tomiyama T; Honzawa Y; Tahara T; Okazaki K; Naganuma M
Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511456
[TBL] [Abstract][Full Text] [Related]
9. Long-term model of colitis-associated colorectal cancer suggests tumor spread mechanism and nature of cancer stem cells.
Tanimura Y; Fukui T; Horitani S; Matsumoto Y; Miyamoto S; Suzuki R; Tanaka T; Tomiyama T; Ikeura T; Ando Y; Nishio A; Okazaki K
Oncol Lett; 2021 Jan; 21(1):7. PubMed ID: 33240413
[TBL] [Abstract][Full Text] [Related]
10. Acceleration of Smad2 and Smad3 phosphorylation via c-Jun NH(2)-terminal kinase during human colorectal carcinogenesis.
Yamagata H; Matsuzaki K; Mori S; Yoshida K; Tahashi Y; Furukawa F; Sekimoto G; Watanabe T; Uemura Y; Sakaida N; Yoshioka K; Kamiyama Y; Seki T; Okazaki K
Cancer Res; 2005 Jan; 65(1):157-65. PubMed ID: 15665291
[TBL] [Abstract][Full Text] [Related]
11. Reversible Smad-dependent signaling between tumor suppression and oncogenesis.
Sekimoto G; Matsuzaki K; Yoshida K; Mori S; Murata M; Seki T; Matsui H; Fujisawa J; Okazaki K
Cancer Res; 2007 Jun; 67(11):5090-6. PubMed ID: 17545585
[TBL] [Abstract][Full Text] [Related]
12. Involvement of Smad3 phosphoisoform-mediated signaling in the development of colonic cancer in IL-10-deficient mice.
Hachimine D; Uchida K; Asada M; Nishio A; Kawamata S; Sekimoto G; Murata M; Yamagata H; Yoshida K; Mori S; Tahashi Y; Matsuzaki K; Okazaki K
Int J Oncol; 2008 Jun; 32(6):1221-6. PubMed ID: 18497983
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical evaluation of phosphorylated SMAD2/SMAD3 and the co-activator P300 in human glomerulonephritis: correlation with renal injury.
Kassimatis TI; Giannopoulou I; Koumoundourou D; Theodorakopoulou E; Varakis I; Nakopoulou L
J Cell Mol Med; 2006; 10(4):908-21. PubMed ID: 17125594
[TBL] [Abstract][Full Text] [Related]
14. Smad2 and Smad3 phosphorylated at both linker and COOH-terminal regions transmit malignant TGF-beta signal in later stages of human colorectal cancer.
Matsuzaki K; Kitano C; Murata M; Sekimoto G; Yoshida K; Uemura Y; Seki T; Taketani S; Fujisawa J; Okazaki K
Cancer Res; 2009 Jul; 69(13):5321-30. PubMed ID: 19531654
[TBL] [Abstract][Full Text] [Related]
15. TRAP1 regulates stemness through Wnt/β-catenin pathway in human colorectal carcinoma.
Lettini G; Sisinni L; Condelli V; Matassa DS; Simeon V; Maddalena F; Gemei M; Lopes E; Vita G; Del Vecchio L; Esposito F; Landriscina M
Cell Death Differ; 2016 Nov; 23(11):1792-1803. PubMed ID: 27662365
[TBL] [Abstract][Full Text] [Related]
16. Decreased levels of active SMAD2 correlate with poor prognosis in gastric cancer.
Wu Y; Li Q; Zhou X; Yu J; Mu Y; Munker S; Xu C; Shen Z; Müllenbach R; Liu Y; Li L; Gretz N; Zieker D; Li J; Matsuzaki K; Li Y; Dooley S; Weng H
PLoS One; 2012; 7(4):e35684. PubMed ID: 22539990
[TBL] [Abstract][Full Text] [Related]
17. Regionally different immunoreactivity for Smurf2 and pSmad2/3 in TDP-43-positive inclusions of amyotrophic lateral sclerosis.
Nakamura M; Kaneko S; Wate R; Asayama S; Nakamura Y; Fujita K; Ito H; Kusaka H
Neuropathol Appl Neurobiol; 2013 Feb; 39(2):144-56. PubMed ID: 22435645
[TBL] [Abstract][Full Text] [Related]
18. Effect of the different phosphorylated Smad2 protein localizations on the invasive breast carcinoma phenotype.
Liapis G; Mylona E; Alexandrou P; Giannopoulou I; Nikolaou I; Markaki S; Keramopoulos A; Nakopoulou L
APMIS; 2007 Feb; 115(2):104-14. PubMed ID: 17295676
[TBL] [Abstract][Full Text] [Related]
19. Temporal and spatial changes of cells positive for stem-like markers in different compartments and stages of human colorectal adenoma-carcinoma sequence.
Cui G; Xu G; Zhu L; Pang Z; Zheng W; Li Z; Yuan A
Oncotarget; 2017 Jul; 8(28):45311-45322. PubMed ID: 28484082
[TBL] [Abstract][Full Text] [Related]
20. Differential expression of p53 family proteins in colorectal adenomas and carcinomas: Prognostic and predictive values.
Bahnassy AA; Zekri AR; Salem SE; Abou-Bakr AA; Sakr MA; Abdel-Samiaa AG; Al-Bradei M
Histol Histopathol; 2014 Feb; 29(2):207-16. PubMed ID: 23996743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
